[Skip to Content]
[Skip to Content Landing]
Article
November 1922

DRUG ERUPTIONS FROM THE CLINICAL ASPECTWITH SPECIAL REFERENCE TO THE RECENT MEDICAMENTS

Author Affiliations

NEW YORK; TOLEDO, OHIO

Arch Derm Syphilol. 1922;6(5):542-564. doi:10.1001/archderm.1922.02360050015002
Abstract

Whoever has read Prince A. Morrow's1 monograph on drug eruptions will surely sympathize with us in our effort to present the subject of "Drug Eruptions from the Clinical Aspect" with the greatest possible expedition; with Morrow's work before us, we feel that little more can be said. The eruptions of his day are, with a few additional examples, those of today. The best course to follow, it seems to us, is to forbear from burdening you with a reiteration of the well-known cutaneous manifestations resulting from the use and abuse of the older drugs, and to devote what time and space is at our disposal to a consideration of eruptions provoked by the recent medicaments. Among the latter are included such widely used drugs as barbital, medinal, adalin, bromural, phenobarbital (luminal), cinchophen, pyramidon, melubrin, acetylsalicylic acid, hexamethylenamin, phenolphthalein and the various arsphenamins.

DEFINITION  As used today, the term "drug

First Page Preview View Large
First page PDF preview
First page PDF preview
×